145 related articles for article (PubMed ID: 9571773)
1. Novel bioactive oxazolomycin isomers produced by Streptomyces albus JA3453.
Kanzaki H; Wada K; Nitoda T; Kawazu K
Biosci Biotechnol Biochem; 1998 Mar; 62(3):438-42. PubMed ID: 9571773
[TBL] [Abstract][Full Text] [Related]
2. Novel triene-beta-lactone antibiotics, oxazolomycin derivative and its isomer, produced by Streptomyces sp. KSM-2690.
Otani T; Yoshida KI; Kubota H; Kawai S; Ito S; Hori H; Ishiyama T; Oki T
J Antibiot (Tokyo); 2000 Dec; 53(12):1397-400. PubMed ID: 11217805
[No Abstract] [Full Text] [Related]
3. The oxazolomycins: a structurally novel class of bioactive compounds.
Moloney MG; Trippier PC; Yaqoob M; Wang Z
Curr Drug Discov Technol; 2004 Oct; 1(3):181-99. PubMed ID: 16472256
[TBL] [Abstract][Full Text] [Related]
4. Oxazolomycin biosynthesis in Streptomyces albus JA3453 featuring an "acyltransferase-less" type I polyketide synthase that incorporates two distinct extender units.
Zhao C; Coughlin JM; Ju J; Zhu D; Wendt-Pienkowski E; Zhou X; Wang Z; Shen B; Deng Z
J Biol Chem; 2010 Jun; 285(26):20097-108. PubMed ID: 20406823
[TBL] [Abstract][Full Text] [Related]
5. Utilization of the methoxymalonyl-acyl carrier protein biosynthesis locus for cloning the oxazolomycin biosynthetic gene cluster from Streptomyces albus JA3453.
Zhao C; Ju J; Christenson SD; Smith WC; Song D; Zhou X; Shen B; Deng Z
J Bacteriol; 2006 Jun; 188(11):4142-7. PubMed ID: 16707707
[TBL] [Abstract][Full Text] [Related]
6. Bisoxazolomycin A: a new natural product from 'Streptomyces subflavus subsp. irumaensis' AM-3603.
Koomsiri W; Inahashi Y; Kimura T; Shiomi K; Takahashi Y; Ōmura S; Thamchaipenet A; Nakashima T
J Antibiot (Tokyo); 2017 Dec; 70(12):1142-1145. PubMed ID: 28951599
[TBL] [Abstract][Full Text] [Related]
7. Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosus.
Manam RR; Teisan S; White DJ; Nicholson B; Grodberg J; Neuteboom ST; Lam KS; Mosca DA; Lloyd GK; Potts BC
J Nat Prod; 2005 Feb; 68(2):240-3. PubMed ID: 15730252
[TBL] [Abstract][Full Text] [Related]
8. Oxazolomycins: natural product lead structures for novel antibacterials by click fragment conjugation.
Bagwell CL; Moloney MG; Yaqoob M
Bioorg Med Chem Lett; 2010 Apr; 20(7):2090-4. PubMed ID: 20223659
[TBL] [Abstract][Full Text] [Related]
9. On the protonophoric activity of oxazolomycin.
Grigorjev PA; Schlegel R; Gräfe U
Pharmazie; 1992 Sep; 47(9):707-9. PubMed ID: 1335580
[TBL] [Abstract][Full Text] [Related]
10. 16-Methyloxazolomycin, a new antimicrobial and cytotoxic substance produced by a Streptomyces sp.
Ryu G; Hwang S; Kim SK
J Antibiot (Tokyo); 1997 Dec; 50(12):1064-6. PubMed ID: 9510916
[No Abstract] [Full Text] [Related]
11. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
[TBL] [Abstract][Full Text] [Related]
12. The first syntheses of the 1-oxo-2-oxa-5-azaspiro[3.4]octane ring system found in oxazolomycin.
Papillon JP; Taylor RJ
Org Lett; 2000 Jul; 2(14):1987-90. PubMed ID: 10891211
[TBL] [Abstract][Full Text] [Related]
13. On the antibiotic activity of oxazolomycin.
Bagwell CL; Moloney MG; Thompson AL
Bioorg Med Chem Lett; 2008 Jul; 18(14):4081-6. PubMed ID: 18558487
[TBL] [Abstract][Full Text] [Related]
14. Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy.
Singh SB; Zink DL; Huber J; Genilloud O; Salazar O; Diez MT; Basilio A; Vicente F; Byrne KM
Org Lett; 2006 Nov; 8(24):5449-52. PubMed ID: 17107044
[TBL] [Abstract][Full Text] [Related]
15. The synergistic antibacterial activity of 1-acetyl-beta-carboline and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
Shin HJ; Lee HS; Lee DS
J Microbiol Biotechnol; 2010 Mar; 20(3):501-5. PubMed ID: 20372018
[TBL] [Abstract][Full Text] [Related]
16. Abenquines A-D: aminoquinone derivatives produced by Streptomyces sp. strain DB634.
Schulz D; Beese P; Ohlendorf B; Erhard A; Zinecker H; Dorador C; Imhoff JF
J Antibiot (Tokyo); 2011 Dec; 64(12):763-8. PubMed ID: 21952099
[TBL] [Abstract][Full Text] [Related]
17. Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356.
Igarashi Y; Futamata K; Fujita T; Sekine A; Senda H; Naoki H; Furumai T
J Antibiot (Tokyo); 2003 Feb; 56(2):107-13. PubMed ID: 12715869
[TBL] [Abstract][Full Text] [Related]
18. A multicomponent coupling strategy suitable for the synthesis of the triene component of the oxazolomycin antibiotics.
Bulger PG; Moloney MG; Trippier PC
Org Biomol Chem; 2003 Nov; 1(21):3726-37. PubMed ID: 14649904
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity composition of the fermentation broth of Streptomyces djakartensis NW35.
Zhang W; Wei S; Zhang J; Wu W
Molecules; 2013 Mar; 18(3):2763-8. PubMed ID: 23455667
[TBL] [Abstract][Full Text] [Related]
20. Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus Strain No. 2445. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation.
Uyeda M; Yokomizo K; Miyamoto Y; Habib EE
J Antibiot (Tokyo); 1998 Sep; 51(9):823-8. PubMed ID: 9820232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
